China National Accord Medicines Corp Ltd (SHE:200028) — Market Cap & Net Worth
Market Cap & Net Worth: China National Accord Medicines Corp Ltd (200028)
China National Accord Medicines Corp Ltd (SHE:200028) has a market capitalization of $125.06 Million (HK$979.65 Million) as of June 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #18386 globally and #4670 in its home market, demonstrating a 1.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China National Accord Medicines Corp Ltd's stock price HK$13.73 by its total outstanding shares 71351280 (71.35 Million). Review 200028 liabilities breakdown to assess the company's total debt and financial obligations.
China National Accord Medicines Corp Ltd Market Cap History: 2015 to 2026
China National Accord Medicines Corp Ltd's market capitalization history from 2015 to 2026. Data shows change from $212.45 Million to $125.06 Million (-4.79% CAGR).
China National Accord Medicines Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China National Accord Medicines Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
China National Accord Medicines Corp Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.11x
China National Accord Medicines Corp Ltd's market cap is 0.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $249.93 Million | $41.25 Billion | $1.19 Billion | 0.01x | 0.21x |
| 2017 | $207.41 Million | $41.26 Billion | $1.06 Billion | 0.01x | 0.20x |
| 2018 | $143.17 Million | $43.12 Billion | $1.21 Billion | 0.00x | 0.12x |
| 2019 | $153.14 Million | $52.79 Billion | $1.27 Billion | 0.00x | 0.12x |
| 2020 | $128.81 Million | $59.65 Billion | $1.40 Billion | 0.00x | 0.09x |
| 2021 | $121.10 Million | $68.36 Billion | $1.34 Billion | 0.00x | 0.09x |
| 2022 | $114.64 Million | $73.44 Billion | $1.49 Billion | 0.00x | 0.08x |
| 2023 | $116.35 Million | $75.48 Billion | $1.60 Billion | 0.00x | 0.07x |
| 2024 | $130.52 Million | $74.38 Billion | $642.49 Million | 0.00x | 0.20x |
| 2025 | $121.60 Million | $71.52 Billion | $1.11 Billion | 0.00x | 0.11x |
Competitor Companies of 200028 by Market Capitalization
Companies near China National Accord Medicines Corp Ltd in the global market cap rankings as of June 4, 2026.
Key companies related to China National Accord Medicines Corp Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #288 globally with a market cap of $88.33 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #533 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1116 globally with a market cap of $23.61 Billion USD ( AU$33.36 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | McKesson Corporation | NYSE:MCK | $88.33 Billion | $739.53 |
| #533 | Cencora Inc. | NYSE:COR | $50.53 Billion | $263.64 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $195.85 |
| #1116 | Sigma Healthcare Ltd | AU:SIG | $23.61 Billion | AU$2.89 |
China National Accord Medicines Corp Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, China National Accord Medicines Corp Ltd's market cap moved from $212.45 Million to $ 125.06 Million, with a yearly change of -4.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | HK$125.06 Million | +2.85% |
| 2025 | HK$121.60 Million | -6.84% |
| 2024 | HK$130.52 Million | +12.18% |
| 2023 | HK$116.35 Million | +1.49% |
| 2022 | HK$114.64 Million | -5.33% |
| 2021 | HK$121.10 Million | -5.98% |
| 2020 | HK$128.81 Million | -15.89% |
| 2019 | HK$153.14 Million | +6.96% |
| 2018 | HK$143.17 Million | -30.97% |
| 2017 | HK$207.41 Million | -17.01% |
| 2016 | HK$249.93 Million | +17.64% |
| 2015 | HK$212.45 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 4th, 2026 the market cap of China National Accord Medicines Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $125.06 Million USD |
| MoneyControl | $125.06 Million USD |
| MarketWatch | $125.06 Million USD |
| marketcap.company | $125.06 Million USD |
| Reuters | $125.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more